Chemring wins biological detection systems contract

Chemring Detection Systems will supply its Joint Biological Point Detection Systems (JBPDS) for the US Army’s Stryker Nuclear Biological Chemical Reconnaissance Vehicle (NBCRV) under a new contract announced on 17 June. The $25.2 million contract was issued by the Aberdeen Contracting Command, and includes associated spare parts and services.

The JBPDS provides automatic detection and identification of airborne biological agents at very low levels, triggers local and remote warning systems, and communicates threat information over standard communication systems.
 
The company will deliver 32 JBPDS under the contract between March 2014 and July 2014.

The JBPDS programme is managed by the Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD).  This system is the only US Biological Detection system that went through the Whole System Live Agent Test (WSLAT).

Mark Papworth, CEO, Chemring Detection Systems, said: ‘We are pleased to have this opportunity to continue our work with the US Army on the production of this unique Joint Biological Point Detection capability. With over 875 systems currently delivered to US forces, the JBPDS continues to provide early warning and identification of biological warfare agents, thereby limiting the effects of biological attacks that have the potential for catastrophic effects on the warfighters.’